Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant Pemetrexed Plus Cisplatin for Pleural Mesothelioma
NCT00087698Phase 2Completed
- Sponsor
- Eli Lilly and Company
- Start
- Sep 2003
- Primary completion
- Feb 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pemetrexed in pleural mesothelioma, sponsored by Eli Lilly and Company. Started Sep 2003; status: completed.
02
Drugs
pemetrexed
03
Conditions
pleural mesothelioma
Beyond the preview
Go deeper on NCT00087698.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00087698.